Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -2258.89% is 64% above its 5-year average of -6231.58%, near the high end of its 5-year range (-18784.77%–-40.46%).
13.10% above its 12-month average of -2599.48%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2227.87%.
NET PROFIT MARGIN
-2258.89%
NET PROFIT MARGIN AVG TTM
-2599.48%
NET PROFIT MARGIN AVG 3Y
-3796.24%
NET PROFIT MARGIN AVG 5Y
-6231.58%
NET PROFIT MARGIN AVG 10Y
-3677.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+13.10%
CURRENT VS 3Y AVG
+40.50%
CURRENT VS 5Y AVG
+63.75%
CURRENT VS 10Y AVG
+38.57%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cibus, Inc.
Market Cap
$129.76M
Net Profit Margin
-2258.89%
TTM Avg
-2599.48%
3Y Avg
-3796.24%
5Y Avg
-6231.58%
Market Cap
$131.11M
Net Profit Margin
-27235.71%
TTM Avg
-16253.49%
3Y Avg
-10565.36%
5Y Avg
-7911.44%
Market Cap
$130.79M
Net Profit Margin
-90.61%
TTM Avg
-39.94%
3Y Avg
-42.38%
5Y Avg
-48.96%
Market Cap
$125.27M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$133.00M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$137.56M
Net Profit Margin
-7.79%
TTM Avg
-6.13%
3Y Avg
-5.81%
5Y Avg
-0.54%
Market Cap
$121.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$118.63M
Net Profit Margin
-52.59%
TTM Avg
-29.17%
3Y Avg
-18.36%
5Y Avg
-9.63%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $129.76M | -2258.89% | -2599.48% | -3796.24% | -6231.58% |
| Entera Bio Ltd. (ENTX)vs › | $131.11M | -27235.71% | -16253.49% | -10565.36% | -7911.44% |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | -90.61% | -39.94% | -42.38% | -48.96% |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| LifeMD, Inc. (LFMD)vs › | $133.00M | -10.40% | -6.28% | -16.07% | -47.85% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $137.56M | -7.79% | -6.13% | -5.81% | -0.54% |
| Freenome, Inc. (FRNM)vs › | $137.20M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| BGM Group Ltd. (BGM)vs › | $118.63M | -52.59% | -29.17% | -18.36% | -9.63% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $120.44M | -2955.63% | -2231.78% | -3480.44% | -3216.57% |
Operating Margin
-1853.9%
Net Profit Margin
-2258.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2227.87% |
| 2026-03-31 | -1262.46% |
| 2025-12-31 | -2959.89% |
| 2025-09-30 | -3827.80% |
| 2025-06-30 | -2719.40% |
| 2025-03-31 | -4534.43% |
| 2024-12-31 | -1906.11% |
| 2024-09-30 | -12437.32% |
| 2024-06-30 | -2969.33% |
| 2024-03-31 | -4300.00% |
| 2023-12-31 | -18784.77% |
| 2023-09-30 | -5564.00% |
| 2023-06-30 | -9487.31% |
| 2023-03-31 | -12842.86% |
| 2022-12-31 | -6754.76% |
| 2022-09-30 | -14166.67% |
| 2022-06-30 | -6060.98% |
| 2022-03-31 | -17559.38% |
| 2021-12-31 | -363.20% |
| 2021-09-30 | -94.14% |
| 2021-06-30 | -40.46% |
| 2021-03-31 | -227.81% |
| 2020-12-31 | -96.19% |
| 2020-09-30 | -180.81% |
| 2020-06-30 | -472.56% |
| 2020-03-31 | -465.42% |
| 2019-12-31 | -323.28% |
| 2019-09-30 | -359.59% |
| 2019-06-30 | -2304.66% |
| 2019-03-31 | -4697.45% |
| 2018-12-31 | -423400.00% |
| 2018-09-30 | -27714.81% |
| 2018-06-30 | -3865.31% |
| 2018-03-31 | -39727.27% |
| 2017-12-31 | -3682.26% |
| 2017-09-30 | -29327.27% |
| 2017-06-30 | -1522.42% |
| 2017-03-31 | -5149.09% |
| 2016-12-31 | -6323.61% |
| 2016-09-30 | -2387.62% |
| 2016-06-30 | -2118.10% |
| 2016-03-31 | -2423.58% |
